Clinical Trial Update: Study of Biomarkers in Blood and/or Tumor Tissue Samples From Patients With Ductal Carcinoma in Situ and From Healthy Volunteers

View source ↗

Summary

This clinical trial investigates biomarkers in blood and tumor tissue from patients with ductal carcinoma in situ and from healthy volunteers.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Ductal Carcinoma in Situ

Snippet

Sponsor: Queen Mary University of London | Conditions: Breast Cancer | Status: UNKNOWN